
	Mr. Sanderson brings to Catabasis more than 25 years of experience in life sciences investment research and financial operations.
	
	Prior to joining Catabasis, Mr. Sanderson was a senior adviser at JSB-Partners, L.P., a global life sciences advisory firm specializing in strategic partnering and M&amp;A transactions. Prior to JSB-Partners, Mr. Sanderson was a managing director at Cowen and Company, LLC, where he spent 20 years as an equity research analyst covering the specialty pharmaceuticals, pharmaceuticals and medical technology sectors. Mr. Sanderson began his life sciences career in healthcare investment banking at Cowen and Company and at Houlihan Lokey Howard and Zukin, and in financial operations at U.S. Surgical Corporation (now Covidien). Mr. Sanderson also served as a director of development-stage, drug delivery technology company Spherics, Inc., advising on strategic and product development.
	
	Mr. Sanderson holds a bachelor&#39;s degree in political economics from Williams College and an MBA in finance from the University of Pennsylvania.
